ResMed (RMD)
(Real Time Quote from BATS)
$243.90 USD
-2.98 (-1.21%)
Updated Nov 3, 2025 11:20 AM ET
3-Hold of 5 3
C Value B Growth C Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
RMD 243.90 -2.98(-1.21%)
Will RMD be a Portfolio Killer in November?
Zacks Investment Research is releasing its prediction for RMD based on the 1-3 month trading system that more than doubles the S&P 500.

Zacks News for RMD
Why ResMed (RMD) is a Top Growth Stock for the Long-Term
Here's How Much You'd Have If You Invested $1000 in ResMed a Decade Ago
RMD: What are Zacks experts saying now?
Zacks Private Portfolio Services
Want Better Returns? Don't Ignore These 2 Medical Stocks Set to Beat Earnings
Earnings Preview: Evolus, Inc. (EOLS) Q2 Earnings Expected to Decline
Will ResMed (RMD) Beat Estimates Again in Its Next Earnings Report?
Other News for RMD
Nvidia To Rally Around 73%? Here Are 10 Top Analyst Forecasts For Monday
RMD: Baird Lowers Price Target for ResMed to $300 While Maintaining Outperform Rating | RMD ...
ResMed price target lowered to $300 from $320 at Baird
ResMed price target lowered by $20 at Baird, here's why
Morgans Reaffirms Their Buy Rating on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD)